BioSpace News Archive

LogistiCare , the nation’s largest non-emergency medical transportation company, today announced it is lacing-up with the National Kidney Foundation (NKF) as a National Multi-Market Sponsor of the Kidney Walk, which raises funds to support kidney health and improve the lives of the 37 million people in the United States affect

ProtoKinetix, Incorporated (www.protokinetix.com) (the “Company” or “ProtoKinetix”) (OTCQB: PKTX), a clinical-stage biomedical company, today announced that Dr. James Shapiro has received approval from Health Canada and the University of Alberta Ethics Committee for the ammendments to the clinical trial protocol.

The use of targeted intraoperative radiotherapy (TARGIT), as a single dose - with ZEISS INTRABEAM - directly after removal of a tumor, has been confirmed as non-inferior, when compared with external beam radiotherapy (EBRT).

Trinity Life Sciences, a global leader in life sciences solutions, today announced it has named two new leaders to its Executive team: Eric Matckie, President of Value & Access and Jeff Uccello, Senior Vice President, Client Development. Both will report directly to Dave Fitzhenry, Trinity’s CEO.

SQI Diagnostics Inc. (“SQI” or the “Company”) (TSX-V: SQD) (OTCQB: SQIDF), today reported its financial and operational results for the three and nine months ended June 30, 2020.

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless cervical cancer detection test based on its patented biophotonic technology, announced that it will meet with the FDA to finalize the protocol for its clinical study in support of its Premarketing Application for the LuViva® Advanced Cervical Scan

AIM ImmunoTech Inc. (NYSE American:AIM) is pleased to announce that it has identified an effective in vitro model at The Institute for Antiviral Research at Utah State University for testing Ampligen, a dsRNA TLR3 agonist, and the results show that Ampligen was able to decrease SARS-CoV-2 infectious viral yields by 90% at clinically achievable intranasal Ampligen dosage levels.

Celcuity Inc. announced today that management will present at the LD 500 Investor Conference, hosted by LD Micro and taking place virtually September 1 - 4, 2020.

Salarius Pharmaceuticals, Inc . (Nasdaq: SLRX), a clinical-stage oncology company targeting cancers caused by dysregulated gene expression, announced today that its Chief Executive Officer, David Arthur, will present during the 2020 LD 500 Conference. The event will take place September 1-4, 2020 via a virtual technology platform. Mr. Arthur will present an overview of Salarius’ business and highlight its recent corporate and clinical achieveme

EPAM Systems, Inc. (NYSE: EPAM), a leading global provider of digital platform engineering and software development services, announced today that TMC, a global, integrated media company, and its TMC Labs product review division, named EPAM’s COVID Resistance App as a 2020 Pandemic Tech Innovation Award winner.